|
|
|
|
|
|
Sponsored by: |
University of Wisconsin, Madison |
Information provided by: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00582712 |
Primary objective is to evaluate the tumor response rate of patients with MTC treated with Lithium carbonate
Condition | Intervention |
Medullary Thyroid Cancer |
Drug: Lithium carbonate |
MedlinePlus related topics: | Cancer Thyroid Cancer |
Drug Information available for: | Thyroid Lithium carbonate Lithium citrate |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Initial Study of Lithium in Patients With Medullary Thyroid Cancer |
Estimated Enrollment: | 5 |
Study Start Date: | January 2008 |
Study Completion Date: | June 2008 |
Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Disease progression is not required for this trial
The following laboratory values obtained within 14 days prior to registration:
Exclusion Criteria:
United States, Wisconsin | |||||
Uniersity of Wisconsin Comprehensive Cancer Center | |||||
Madison, Wisconsin, United States, 53792 |
University of Wisconsin, Madison |
Principal Investigator: | Herbert Chen, MD | University of Wisconsin Cancer Center |
Responsible Party: | University of Wisconsin Cancer Center ( Sarah Schaefer ) |
Study ID Numbers: | 2007-0195, CO 07312 |
First Received: | December 19, 2007 |
Last Updated: | June 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00582712 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
|